Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
PRAX

Praxis Precision Medicines, Inc. (PRAX)

NASDAQ
$304.90
+$0.58
(+0.19%)
Previous Close: ⁦$305.06⁩
Market Closed

Last updated: ⁦2026-11-19 02:45:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Praxis Precision Medicines, Inc. (PRAX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $304.90, with a market capitalization of $8.67B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $160.11 to $392.70. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$8.67B

$304.36

$314.22

$299.00

$305.06

377.09K

472.60K

--

$392.70

$160.11

--

2026-09-30

Praxis Precision Medicines, Inc. (PRAX) Latest Closing Stock Price

Praxis Precision Medicines, Inc. (PRAX) last closed at $304.90 as of 2026-11-19 00:58:00, up 0.19% ($0.58) from the previous close of $305.06.

During the latest regular trading session, PRAX traded between $299.00 and $314.22, with a volume of 377.09K shares. The closing price was near the middle and near the middle of its 52-week range.

Praxis Precision Medicines, Inc. (PRAX) 7-Day Stock Price Change

Over the past seven days, Praxis Precision Medicines, Inc. (PRAX) moved from $332.97 to $304.90, representing a decline of 8.43% ($28.07).

The stock traded between $279.14 and $351.64 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.

The average daily volume was 692.22 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

PRAX 52-Week Price Position

Position in Range: 62.3%

52W Low$160.11
52W High$392.70

PRAX is currently trading at $304.90, placing it 62.3% of the way from its 52-week low of $160.11 to its 52-week high of $392.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Praxis Precision Medicines, Inc. (PRAX)?

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Praxis Precision Medicines, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
10,998
Exchange
NASDAQ
Company Website

PRAX News

Latest news related to Praxis Precision Medicines, Inc. and PRAX stock.

  • Benzinga

    This Elevance Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

    Wall Street analysts upgraded TIGO, MWH, CNX, TNDM and ELV, with mixed price-target changes.

    Read Full Article
  • Benzinga

    This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

    Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.

    Read Full Article
  • Benzinga

    Wells Fargo Upgrades Praxis Precision Medicine to Overweight, Raises Price Target to $509

    Wells Fargo analyst Benjamin Burnett upgrades Praxis Precision Medicine (NASDAQ:PRAX) from Equal-Weight to Overweight and raises the price target from $343 to $509.

    Read Full Article
  • Benzinga

    Guggenheim Maintains Buy on Praxis Precision Medicine, Raises Price Target to $1050

    Guggenheim analyst Yatin Suneja maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $800 to $1050.

    Read Full Article
  • Benzinga

    Baird Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $568

    Baird analyst Joel Beatty maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $514 to $568.

    Read Full Article

Ways to Trade PRAX at MEXC

PRAX MEXC RealStocks

Own real PRAX shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Praxis Precision Medicines, Inc. (PRAX) Stock on MEXC

Eligible investors can buy real shares of Praxis Precision Medicines, Inc. (PRAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for PRAX and Place Your Order
Step 3: Search for PRAX and Place Your Order
Open the RealStocks trading page and search for PRAX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Praxis Precision Medicines, Inc. (PRAX) stock price today?
Praxis Precision Medicines, Inc. (PRAX) is currently trading at $304.90, up 0.19% ($0.58) from the previous close of $305.06. Intraday prices update in real time during regular trading hours.
2.Is PRAX stock going up or down today?
As of 2026-11-19 00:58:00, PRAX is trading at $304.90, up 0.19% ($0.58) from its previous close of $305.06. The stock has traded between $299.00 and $314.22 during today’s regular session. Past price movements do not guarantee future results.
3.What is PRAX pre-market price?
As of 2026-11-19 00:58:00, PRAX is trading at $300.25 in pre-market trading, down 1.58% ($4.81) from the previous close of $305.06. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is PRAX after-hours price?
As of 2026-11-19 00:58:00, PRAX is trading at $305.50 in after-hours trading, up 0.20% ($0.60) from the regular-session close of $304.90. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is PRAX stock trading now?
PRAX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does PRAX sit relative to its 52-week high and low?
Over the past 52 weeks, PRAX has traded between a low of $160.11 and a high of $392.70. At $304.90, the stock is positioned 62.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Praxis Precision Medicines, Inc. in?
Praxis Precision Medicines, Inc. (PRAX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Praxis Precision Medicines, Inc.'s market capitalization and where is it listed?
Praxis Precision Medicines, Inc. is listed on the NASDAQ exchange with a market capitalization of $8.67B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is PRAX valued in terms of P/E ratio and EPS?
PRAX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-12.86. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Praxis Precision Medicines, Inc. pay a dividend?
Praxis Precision Medicines, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PRAX, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

PRAX Stock Calculator

Estimate the value between PRAX shares and USD.

PRAX Shares to USD

PRAX Shares
PRAX
PRAX
USD
USD
USD

1.00 PRAX shares = 304.901 USD

Calculations are estimates based on the latest available price and are for reference only.